Superior Genomics, Inc.
PrivateLast Round
Seed
Jul 30, 2026
Total Funding Raised
$4,100
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Superior Genomics, Inc. operates in Healthcare & Life Sciences and is based in Norway, Michigan. Its latest recorded funding round was a Grant round in December 2024.
Superior Genomics, Inc. is a health technology company that develops blood-based gene expression diagnostic tests for mental health disorders such as Major Depressive Disorder and Bipolar Disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Superior Genomics, Inc. Comparables
Compare Superior Genomics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laguna Diagnostics, LLC | 85% | |
| MindX Sciences | 83% | |
| ALCEN | 82% |
For institutional investors. Book with your work email.
Superior Genomics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 30, 2026 | ||||
| Grant | Dec 1, 2024 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
$508K raised in Seed Round.
- Dec 1, 2024
Received $4.1K grant from Central Upper Peninsula Small Business Support Hub.
For institutional investors. Book with your work email.
Superior Genomics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Superior Genomics, Inc.'s valuation, stock price, and market status.
Is Superior Genomics, Inc. a public or private company?
Superior Genomics, Inc. is a private company.
What is the current stock price of Superior Genomics, Inc.?
Superior Genomics, Inc. is a private company, so its shares have no public market price. Caplight tracks Superior Genomics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Superior Genomics, Inc. worth (valuation)?
Valuation information for Superior Genomics, Inc. is not publicly available.
Can I buy Superior Genomics, Inc. stock?
Superior Genomics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Superior Genomics, Inc.'s last funding round?
Superior Genomics, Inc.'s most recent funding round was Seed on July 30, 2026.
Who are the main investors in Superior Genomics, Inc.?
Investor information for Superior Genomics, Inc. is not publicly disclosed.
Will Superior Genomics, Inc. IPO soon?
No public IPO plans have been announced for Superior Genomics, Inc..
How can I track Superior Genomics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Superior Genomics, Inc.'s shares on secondary markets.